Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Run Zhuang

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|December 2, 2015
Discovery of the imidazole-derived GPR40 agonist AM-3189Zhihua Ma, Daniel C-H Lin, Rajiv Sharma, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Optimization of GPR40 Agonists for Type 2 DiabetesJiwen Jim Liu, Yingcai Wang, Zhihua Ma, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improving the Pharmacokinetics of GPR40/FFA1 Full AgonistsXiaohui Du, Paul J Dransfield, Daniel C-H Lin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy StudiesMing Yu, Mike Lizarzaburu, Alykhan Motani, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic SpirocyclesYingcai Wang, Jiwen Jim Liu, Paul J Dransfield, et al.
Pageof 2